According to surveys of the Central Drugs Standard Control Organization (CDSCO), the official regulatory authority of India, about 4.5% of medicines on the Indian market are substandard. However, substandard drugs could be three times more widespread in India.
According to experts at the origin of a study conducted on 32 samples of diclofenac sodium – a popular painkiller – and published in December 2015 in the Journal of Applied Pharmaceutical Science, more drugs are lucrative, the more likely that they do not meet quality standards. Conclusions confirmed by a second study, published in January 2016 in the Journal of Pharmacy and Pharmaceutical Sciences, carried out on 46 samples of amoxicillin trihydrate, an antibiotic.
Two studies have also revealed a proportion of sub-standard medicines of 15.62% for diclofenac sodium and 13.04% for amoxicillin trihydrate.
Source: First Post IndiaBack to previous